Sign in

CIK 0001088856 · Large accelerated filer

CORCEPT THERAPEUTICS INC

Sign in to watch
Ticker
CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770487658
Phone
650.688.8803
Business address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$41,067,988
in 15 filings, $36.6M under 10b5-1 plans

Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-11-01 Guyer William Chief Development Officer Option exercise · Stock option (right to buy) 10b5-1 −6,606 453,394
2024-10-01 Guyer William Chief Development Officer Option exercise 10b5-1 +10,000 $21.65 $217K 15,796
2024-10-01 Guyer William Chief Development Officer Sale 10b5-1 −10,000 $46.28 $463K 5,796
2024-10-01 Guyer William Chief Development Officer Option exercise · Stock option (right to buy) 10b5-1 −10,000 460,000
2024-10-01 Robb Gary Charles Chief Business Officer Option exercise 10b5-1 +11,000 $3.29 $36K 33,772
2024-10-01 Robb Gary Charles Chief Business Officer Sale 10b5-1 −11,000 $46.28 $509K 22,772
2024-10-01 Robb Gary Charles Chief Business Officer Option exercise · Stock option (right to buy) 10b5-1 −11,000 14,037
2024-09-27 Robb Gary Charles Chief Business Officer Gift 10b5-1 +415 9,665
2024-09-27 Robb Gary Charles Chief Business Officer Gift 10b5-1 +415 9,665
2024-09-18 Robb Gary Charles Chief Business Officer Gift −870 22,772
2024-09-18 Robb Gary Charles Chief Business Officer Other disposition −7,250 0
2024-09-17 Robb Gary Charles Chief Business Officer Gift −300 23,642
2024-09-03 Lyon Joseph Douglas See Remarks Shares withheld for taxes −129 $35.30 $5K 9,161
2024-09-03 Lyon Joseph Douglas See Remarks Grant or award +372 $34.26 $13K 9,533
2024-09-03 Lyon Joseph Douglas See Remarks Grant or award +372 9,905
2024-09-03 Mokari Atabak Chief Financial Officer Shares withheld for taxes −143 $35.30 $5K 11,718
2024-09-03 Mokari Atabak Chief Financial Officer Grant or award +400 $34.26 $14K 12,118
2024-09-03 Mokari Atabak Chief Financial Officer Grant or award +400 12,518
2024-09-03 Maduck Sean See Remarks Shares withheld for taxes −232 $35.30 $8K 84,167
2024-09-03 Maduck Sean See Remarks Grant or award +458 $34.26 $16K 84,625

Page 35 of 61 · 1,220 trades